5081 - 5090 of 7915 Results
Title
Year
-
OPENTitle: Clinical implications of early caudate dysfunction in Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 90Issue #: 10Start Page: 1098End Page: 1104Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/jnnp-2018-320157Best OA location URL: https://jnnp.bmj.com/content/jnnp/90/10/1098.full.pdfCitation Count: 63
-
OPENTitle: Early‐onset pathologically proven multiple system atrophy with LRRK2 G2019S mutationJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 7Start Page: 1080End Page: 1082Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27710Best OA location URL: https://europepmc.org/articles/pmc6642007?pdf=renderCitation Count: 21
- Identifying and ranking potential driver genes of Alzheimer’s disease using multiview evidence aggregation2019OPENTitle: Identifying and ranking potential driver genes of Alzheimer’s disease using multiview evidence aggregationJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 35Issue #: 14Start Page: i568End Page: i576Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/bioinformatics/btz365Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/35/14/i568/28913444/btz365.pdfCitation Count: 14
- Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confounding2019OPENTitle: Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confoundingJournal Name: Annals of EpidemiologyPublisher: Elsevier BVVol: 35Issue #:Start Page: 42End Page: 47.e1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.annepidem.2019.04.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074509Citation Count: 11
-
OPENTitle: Regional neuropathology distribution and verbal fluency impairments in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 73End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.014Best OA location URL: http://manuscript.elsevier.com/S1353802019302354/pdf/S1353802019302354.pdfCitation Count: 16
-
OPENTitle: Spring is in the air: seasonal profiles indicate vernal change of miRNA activityJournal Name: RNA BiologyPublisher: Informa UK LimitedVol: 16Issue #: 8Start Page: 1034End Page: 1043Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15476286.2019.1612217Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15476286.2019.1612217?needAccess=trueCitation Count: 14
- Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s disease2019OPENTitle: Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s diseaseJournal Name: Current Opinion in PhysiologyPublisher: Elsevier BVVol: 9Issue #:Start Page: 73End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.cophys.2019.04.025Best OA location URL: https://doi.org/10.1016/j.cophys.2019.04.025Citation Count: 8
- Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort2019OPENTitle: Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohortJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 266Issue #: 8Start Page: 1927End Page: 1936Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-019-09348-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-019-09348-3.pdfCitation Count: 125
- The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss2019OPENTitle: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592621Citation Count: 9
-
OPENTitle: TREM2 brain transcript-specific studies in AD and TREM2 mutation carriersJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-019-0319-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-019-0319-3Citation Count: 74